The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Open accessAbstract
BACKGROUND: Although the short-term benefits of bilateral stimulation of the subthalamic nucleus in patients with advanced Parkinson's disease have been well documented, the long-term outcomes of the procedure are unknown. METHODS: We conducted a five-year prospective study of the first 49 consecutive patients whom we treated with bilateral stimulation of the subthalamic nucleus. Patients were assessed at one, three, and five years with levodopa (on medication) and without levodopa (off medication), with use of the Unified Parkinson's Disease Rating Scale. Seven patients did not complete the study: three died, and four were lost to follow-up. RESULTS: As compared with base line, the patients' scores at five years for motor function while off medication improved by 54 percent (P<0.001) and those for activities of daily living improved by 49 percent (P<0.001). Speech was the only motor function for which off-medication scores did not improve. The scores for motor function on medication did not improve one year after surgery, except for the dyskinesia scores. On-medication akinesia, speech, postural stability, and freezing of gait worsened between year 1 and year 5 (P<0.001 for all comparisons). At five years, the dose of dopaminergic treatment and the duration and severity of levodopa-induced dyskinesia were reduced, as compared with base line (P<0.001 for each comparison). The average scores for cognitive performance remained unchanged, but dementia developed in three patients after three years. Mean depression scores remained unchanged. Severe adverse events included a large intracerebral hemorrhage in one patient. One patient committed suicide. CONCLUSIONS: Patients with advanced Parkinson's disease who were treated with bilateral stimulation of the subthalamic nucleus had marked improvements over five years in motor function while off medication and in dyskinesia while on medication. There was no control group, but worsening of akinesia, speech, postural stability, freezing of gait, and cognitive function between the first and the fifth year is consistent with the natural history of Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853
Self-citation(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
Core assessment program for intracerebral transplantations (CAPIT)
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., & Watts, R. (1992) · Movement Disorders · doi:10.1002/mds.870070103 · Cited by 1,008
Kumar, R., Lozano, A. M., Kim, Y. J., Hutchison, W. D., Sime, E., Halket, E., & Lang, A. E. (1998) · Neurology · doi:10.1212/wnl.51.3.850 · Cited by 634
Differential diagnosis and classification of apathy
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.1.22 · Cited by 620
Behavioural disorders, Parkinson's disease and subthalamic stimulation
Houeto, J. L. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.701 · Cited by 500
The impact of deep brain stimulation on executive function in Parkinson's disease
Jahanshahi, M., Ardouin, C. M. A., Brown, R. G., Rothwell, J. C., Obeso, J., Albanese, A., Rodriguez-Oroz, M. C., Moro, E., Benabid, A. L., Pollak, P., et al. (2000) · Brain · doi:10.1093/brain/123.6.1142 · Cited by 425
Self-citationLong-term Hardware-related Complications of Deep Brain Stimulation
Oh, M. Y., Abosch, A., Kim, S. H., Lang, A. E., & Lozano, A. M. (2002) · Neurosurgery · doi:10.1097/00006123-200206000-00017 · Cited by 405
Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson’s disease
Pillon, B., Ardouin, C., Damier, P., Krack, P., Houeto, J. L., Klinger, H., Bonnet, A. M., Pollak, P., Benabid, A. L., & Agid, Y. (2000) · Neurology · doi:10.1212/wnl.55.3.411 · Cited by 332
Self-citationLong‐term efficacy of thalamic deep brain stimulation for tremor: Double‐blind assessments
Rehncrona, S., Johnels, B., Widner, H., Törnqvist, A., Hariz, M., & Sydow, O. (2003) · Movement Disorders · doi:10.1002/mds.10309 · Cited by 324
Interrater reliability of the unified Parkinson's disease rating scale motor examination
Richards, M., Marder, K., Cote, L., & Mayeux, R. (1994) · Movement Disorders · doi:10.1002/mds.870090114 · Cited by 318
Effect on mood of subthalamic DBS for Parkinson’s disease A consecutive series of 24 patients
Berney, A., Vingerhoets, F., Perrin, A., Guex, P., Villemure, J.-G., Burkhard, P. R., Benkelfat, C., & Ghika, J. (2002) · Neurology · doi:10.1212/01.wnl.0000032756.14298.18 · Cited by 310
Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions?
Bonnet, A.-M., Loria, Y., Saint-Hilaire, M.-H., Lhermitte, F., & Agid, Y. (1987) · Neurology · doi:10.1212/wnl.37.9.1539 · Cited by 284
Postoperative management of subthalamic nucleus stimulation for Parkinson's disease
Krack, P., Fraix, V., Mendes, A., Benabid, A.-L., & Pollak, P. (2002) · Movement Disorders · doi:10.1002/mds.10163 · Cited by 267
Self-citationRomito, L. M., Raja, M., Daniele, A., Contarino, M. F., Bentivoglio, A. R., Barbier, A., Scerrati, M., & Albanese, A. (2002) · Movement Disorders · doi:10.1002/mds.10265 · Cited by 266
Long-Term Follow-up of Unilateral Pallidotomy in Advanced Parkinson's Disease
Fine, J., Duff, J., Chen, R., Hutchison, W., Lozano, A. M., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422304 · Cited by 266
Funkiewiez, A., Ardouin, C., Krack, P., Fraix, V., Van Blercom, N., Xie, J., Moro, E., Benabid, A., & Pollak, P. (2003) · Movement Disorders · doi:10.1002/mds.10441 · Cited by 264
Self-citationGhika, J., Villemure, J.-G., Fankhauser, H., Favre, J., Assal, G., & Ghika-Schmid, F. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.5.0713 · Cited by 250
Krack, P. (1999) · Brain · doi:10.1093/brain/122.6.1133 · Cited by 229
Self-citationBook Review: Third Symposium on Parkinson's Disease
Turner, J. W. A. (1970) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577006300567 · Cited by 214
The Mattis Dementia Rating Scale: Normative data from 1,001 healthy volunteers
Schmidt, R., Freidl, W., Fazekas, F., Reinhart, B., Grieshofer, P., Koch, M., Eber, B., Schumacher, M., Polmin, K., & Lechner, H. (1994) · Neurology · doi:10.1212/wnl.44.5.964 · Cited by 186
Krack, P., Limousin, P., Benabid, A., & Pollak, P. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64273-0 · Cited by 165
Self-citationObjective changes in motor function during placebo treatment in PD
Goetz, C. G., Leurgans, S., Raman, R., & Stebbins, G. T. (2000) · Neurology · doi:10.1212/wnl.54.3.710 · Cited by 162
Doshi, P. K., Chhaya, N., & Bhatt, M. H. (2002) · Movement Disorders · doi:10.1002/mds.10198 · Cited by 157
The spectrum of levodopa‐related fluctuations in Parkinson's disease
Riley, D. E., & Lang, A. E. (1993) · Neurology · doi:10.1212/wnl.43.8.1459 · Cited by 155
Ghika, J. A., Ghika-Schmid, F., Fankhauser, H., ASSAL, G., Vingerhoets, F. J. G., Albanese, A., Bogousslavsky, J., & Favre, J. (1999) · Journal of neurosurgery · doi:10.3171/jns.1999.91.2.0313 · Cited by 150
Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up
Pahwa, R., Wilkinson, S. B., Overman, J. W., & Lyons, K. E. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.1.0071 · Cited by 144
Pallidotomy for Parkinson disease: a review of contemporary literature
Alkhani, A. M., & Lozano, A. M. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.94.1.0043 · Cited by 138
Goetz, C. G., Leurgans, S. E., & Raman, R. (2002) · Movement Disorders · doi:10.1002/mds.10024 · Cited by 135
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
Albanese, A., Bonuccelli, U., Brefel‐Courbon, C., Chaudhuri, К. R., Colosimo, C., Eichhorn, T. E., Melamed, E., Pollak, P., van Laar, T., & Zappia, M. (2001) · Movement Disorders · doi:10.1002/mds.1069 · Cited by 131
Self-citationIndividual manifestations of Parkinson's disease after ten or more years of levodopa
Klawans, H. L. (1986) · Movement Disorders · doi:10.1002/mds.870010304 · Cited by 127
Long‐term follow‐up of early dopa treatment in Parkinson's disease
Markham, C. H., & Diamond, S. G. (1986) · Annals of Neurology · doi:10.1002/ana.410190410 · Cited by 109
Hariz, M., & Bergenheim, A. T. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.94.4.0552 · Cited by 76
Bilateral pallidotomy in Parkinson's disease: A retrospective study
de Bie, R. M. A., Schuurman, P. R., Esselink, R. A. J., Bosch, D. A., & Speelman, J. D. (2002) · Movement Disorders · doi:10.1002/mds.10090 · Cited by 71
Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
Greene, P., Côté, L., & Fahn, S. (1993) · PubMed · Cited by 71
Long‐Term follow‐up of globus pallidus chronic stimulation in advanced Parkinson's disease
Durif, F., Lemaire, J., Debilly, B., & Dordain, G. (2002) · Movement Disorders · doi:10.1002/mds.10128 · Cited by 63
Speelman, J. D., Schuurman, P. R., de Bie, R. M. A., & Bosch, D. A. (2008) · Movement Disorders · doi:10.1002/mds.870131318 · Cited by 36
Hariz, G., Lindberg, M., Hariz, M. I., & Bergenheim, A. T. (2002) · Movement Disorders · doi:10.1002/mds.10386 · Cited by 31
Cited by
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944
Self-citationLees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Weaver, F. M. (2009) · JAMA · doi:10.1001/jama.2008.929 · Cited by 1,525
Neurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430
Self-citationPallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Follett, K. A., Weaver, F. M., Stern, M., Hur, K., Harris, C. L., Luo, P., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907083 · Cited by 1,355
Metadata
- Authors
- Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., Benabid, A.-L., & Pollak, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-11-13
- Volume
- 349
- Issue
- 20
- Pages
- 1925-1934
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095270577
- Cited by
- 2,249
- References
- 43
- FWCI
- 55.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.